-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
OBJECTIVE: To assess the effect of mean adjusted global APS total score (aGAPSS) on recurrence of clinical manifestations in patients with antiphospholipid syndrome (APS) in a retrospective longitudinal study
Methods: The study included 200 patients with APS
In patients taking vitamin K antagonists (VKA), the percentage of time spent in the therapeutic range (TTR) was calculated
Results: The mean aGAPSS value of patients with clinical recurrence was higher than that of patients without recurrence [8.
The mean aGAPSS value of patients with recurrent thrombosis was higher than that of patients with recurrent miscarriage [9.
The mean aGAPSS value of patients with arterial thrombosis was higher than that of patients with venous thrombosis [10.
In multivariate analysis, aGAPSS values >13 were associated with the highest risk of recurrence [HR = 3.
Conclusions: Data from this study support the role of regular (annual) monitoring of the aGAPSS score in predicting clinical relapse in patients with APS
Source:
Barilaro G, Esteves A, Della Rocca C, et al.